Insights : sector - Osborne Clarke

Life Sciences and Healthcare

Industries making an impact on modern society

Life sciences, health and social care are vitally important in the development of modern society, with a complex network of stakeholders, from the general public and clinical practitioners to regulators, insurers and governments. We understand the unique challenges of the industry and deliver results-focused advice for a diverse range of clients, from drug developers to healthcare providers and the entities that finance and support them.

Learn more about this sector

Article list

Life Sciences and Healthcare

Telemedicine in Italy takes next step following pandemic regulatory advance

The 'care relationship' between the physician and the patient will be transformed by telemedicine if not superseded

New -

30/01/2023

Read time 5m

Life Sciences and Healthcare

Telemedicine in Italy takes next step following pandemic regulatory advance

30/01/2023

Read time 5m

Corporate

2023 predictions: What's on the horizon for US businesses operating in Europe?

By staying ahead of the curve and preparing for changes, US businesses can remain competitive and successful in Europe

17/01/2023

Life Sciences and Healthcare

Pharma industry watches as UK Court of Appeal considers issue of plausibility

Decisions to invalidate blood clot drug patents are appealed

13/01/2023

Life Sciences and Healthcare

New year brings healthcare professional interaction rule update in Belgium

The new rules offer more flexibility to life sciences businesses interacting with health professionals and organisations

04/01/2023

Life Sciences and Healthcare

Products without an intended medical purpose: EU clarifies conditions

Non-medical product manufacturers have limited time to prepare for new risk management and clinical data obligations

20/12/2022

Life Sciences and Healthcare

The UK Patents Court puts an arrow through Teva's application for declaratory relief

Court of Appeal makes clear the limits on obtaining Arrow declaratory relief for deployment in other jurisdictions

15/12/2022

Intellectual property

Could international and European legal obstacles jeopardise the German government's legislative plan to legalise cannabis?

German government publishes paper with legislative proposals, but the impact of international and European law on its plan is still...

15/12/2022

Life Sciences and Healthcare

Regulatory Horizons Council makes recommendations to UK government for the regulation of AI as a medical device

'Urgent need to get the regulation right' says RHC report which recommends an increase in regulatory capacity and capability to...

12/12/2022

Regulatory Outlook

Products | UK Regulatory Outlook November 2022

Government further delays use of UK product safety marking | UK-wide packaging regulations expected to enter into force in late...

30/11/2022

Life Sciences and Healthcare

Commercialising health data: five takeaways from the ICO's Easylife decision

What actions should businesses consider when looking to reuse customer health data?

11/11/2022

Life Sciences and Healthcare

EU General Court says risk of similarity between cosmetics and pharmaceuticals in trade mark cases

A blurred line between goods means skincare products may be considered similar across classes 3 and 5

08/11/2022

Regulatory and compliance

New Belgian medical devices and in vitro diagnostics legislation comes into force

The transposition of EU medtech regulations is progressing in Belgium – with repercussions for all medtech businesses active there.

08/11/2022

Life Sciences and Healthcare

UK lays out roadmap for regulation of software and AI as medical devices

What 'deliverables' does the MHRA want from its roadmap and what can be expected from its work packages?

28/10/2022

Life Sciences and Healthcare

MHRA moves to assuage medical device manufacturers over UK's post-Brexit plans

Businesses will have more time to prepare for the new UKCA marking regime and comment on draft medical device regulations

26/10/2022

Intellectual property

Implausible declarations?

What a recent English Patents Court judgment suggests for the future of litigation

17/10/2022

View all insights

Life Sciences and Healthcare

Telemedicine in Italy takes next step following pandemic regulatory advance

The 'care relationship' between the physician and the patient will be transformed by telemedicine if not superseded

New -

30/01/2023

Read time 5m

Life Sciences and Healthcare

Telemedicine in Italy takes next step following pandemic regulatory advance

30/01/2023

Read time 5m

Corporate

2023 predictions: What's on the horizon for US businesses operating in Europe?

By staying ahead of the curve and preparing for changes, US businesses can remain competitive and successful in Europe

17/01/2023

Life Sciences and Healthcare

Pharma industry watches as UK Court of Appeal considers issue of plausibility

Decisions to invalidate blood clot drug patents are appealed

13/01/2023

Life Sciences and Healthcare

New year brings healthcare professional interaction rule update in Belgium

The new rules offer more flexibility to life sciences businesses interacting with health professionals and organisations

04/01/2023

Life Sciences and Healthcare

Products without an intended medical purpose: EU clarifies conditions

Non-medical product manufacturers have limited time to prepare for new risk management and clinical data obligations

20/12/2022

Life Sciences and Healthcare

The UK Patents Court puts an arrow through Teva's application for declaratory relief

Court of Appeal makes clear the limits on obtaining Arrow declaratory relief for deployment in other jurisdictions

15/12/2022

Intellectual property

Could international and European legal obstacles jeopardise the German government's legislative plan to legalise cannabis?

German government publishes paper with legislative proposals, but the impact of international and European law on its plan is still...

15/12/2022

Life Sciences and Healthcare

Regulatory Horizons Council makes recommendations to UK government for the regulation of AI as a medical device

'Urgent need to get the regulation right' says RHC report which recommends an increase in regulatory capacity and capability to...

12/12/2022

Regulatory Outlook

Products | UK Regulatory Outlook November 2022

Government further delays use of UK product safety marking | UK-wide packaging regulations expected to enter into force in late...

30/11/2022

Life Sciences and Healthcare

Commercialising health data: five takeaways from the ICO's Easylife decision

What actions should businesses consider when looking to reuse customer health data?

11/11/2022

Life Sciences and Healthcare

EU General Court says risk of similarity between cosmetics and pharmaceuticals in trade mark cases

A blurred line between goods means skincare products may be considered similar across classes 3 and 5

08/11/2022

Regulatory and compliance

New Belgian medical devices and in vitro diagnostics legislation comes into force

The transposition of EU medtech regulations is progressing in Belgium – with repercussions for all medtech businesses active there.

08/11/2022

Life Sciences and Healthcare

UK lays out roadmap for regulation of software and AI as medical devices

What 'deliverables' does the MHRA want from its roadmap and what can be expected from its work packages?

28/10/2022

Life Sciences and Healthcare

MHRA moves to assuage medical device manufacturers over UK's post-Brexit plans

Businesses will have more time to prepare for the new UKCA marking regime and comment on draft medical device regulations

26/10/2022

Intellectual property

Implausible declarations?

What a recent English Patents Court judgment suggests for the future of litigation

17/10/2022

View all insights

Will James

Partner, International Life Sciences and Healthcare Sector Leader, UK

+44 207 105 7774 Email Will Full biog

Silvia Steiner

Partner, Spain

+34 93 419 18 18 Email Silvia Full biog

Dr Tim Reinhard

Partner, Wirtschaftsmediator (MuCDR), Germany

+49 89 5434 8024 Email Tim Full biog

Thomas Devred

Partner, France

+ 33 1 84 82 41 06 Email Thomas Full biog

Maria Grazia Medici

Partner, Head of Life Sciences & Healthcare, Italy

+39 06 3269 5015 Email Maria Grazia Full biog

Hadrien Chef

Partner, Belgium

+32 2 515 93 24 Email Hadrien Full biog

Herke van Hulst

Partner, Advocaat, The Netherlands

+31 207028672 Email Herke Full biog

Catherine Wolfenden

Partner, Disputes & Risk Practice Group Head, UK

+44 117 917 3600 Email Catherine Full biog

Matthew Edwards

Partner, UK

+44 207 105 7786 Email Matthew Full biog

Marcus Vass

Partner, UK

UK +44 2071 057 634 Email Marcus Full biog

Rafael García del Poyo

Partner, Spain

+34 91 576 44 76 Email Rafael Full biog

Peter Rudd-Clarke

Partner, UK

+44 207 105 7315 Email Peter Full biog

Tim Harris

Partner, UK

+44 207 105 7144 Email Tim Full biog

Giulia Verusio

Associate, Italy

+39 06 3269 5008 Email Giulia Full biog

J. Carlos Suarez

Of Counsel, Italy

+39 02 5413 1772 Email J. Carlos Full biog

David Haex

Managing Partner, Belgium

+32 2 515 9322 Email David Full biog

Xavier Pican

Partner, France

+33 1 84 82 45 88 Email Xavier Full biog

Dr Andrea Schmoll

Partner, Germany

+49 221 5108 4298 Email Andrea Full biog

Dr Flemming Moos

Partner, Specialist lawyer for IT law, Germany

+49 40 55436 4054 Email Flemming Full biog

Dr Martin Sundermann

Partner, Wirtschaftsmediator (MuCDR), Germany

+49 89 5434 8026 Email Martin Full biog

Marie-Louise Weeda

Partner, Advocaat, The Netherlands

+31 20 702 8698 Email Marie-Louise Full biog

Steve Wilson

Managing Partner, US

+1 917 545 3672 Email Steve Full biog

Jordi Casas

Co-Managing Partner, Spain

+34 93 419 18 18 Email Jordi Full biog

Julia Kaufmann, LL.M.

Partner, Germany

+49 89 5434 8068 Email Julia Full biog

View all

Search results

Insights

Life Sciences and Healthcare

Industries making an impact on modern society

Article list

Telemedicine in Italy takes next step following pandemic regulatory advance

Telemedicine in Italy takes next step following pandemic regulatory advance

2023 predictions: What's on the horizon for US businesses operating in Europe?

Pharma industry watches as UK Court of Appeal considers issue of plausibility

New year brings healthcare professional interaction rule update in Belgium

Products without an intended medical purpose: EU clarifies conditions

The UK Patents Court puts an arrow through Teva's application for declaratory relief

Could international and European legal obstacles jeopardise the German government's legislative plan to legalise cannabis?

Regulatory Horizons Council makes recommendations to UK government for the regulation of AI as a medical device

Products | UK Regulatory Outlook November 2022

Commercialising health data: five takeaways from the ICO's Easylife decision

EU General Court says risk of similarity between cosmetics and pharmaceuticals in trade mark cases

New Belgian medical devices and in vitro diagnostics legislation comes into force

UK lays out roadmap for regulation of software and AI as medical devices

MHRA moves to assuage medical device manufacturers over UK's post-Brexit plans

Implausible declarations?

Telemedicine in Italy takes next step following pandemic regulatory advance

Telemedicine in Italy takes next step following pandemic regulatory advance

2023 predictions: What's on the horizon for US businesses operating in Europe?

Pharma industry watches as UK Court of Appeal considers issue of plausibility

New year brings healthcare professional interaction rule update in Belgium

Products without an intended medical purpose: EU clarifies conditions

The UK Patents Court puts an arrow through Teva's application for declaratory relief

Could international and European legal obstacles jeopardise the German government's legislative plan to legalise cannabis?

Regulatory Horizons Council makes recommendations to UK government for the regulation of AI as a medical device

Products | UK Regulatory Outlook November 2022

Commercialising health data: five takeaways from the ICO's Easylife decision

EU General Court says risk of similarity between cosmetics and pharmaceuticals in trade mark cases

New Belgian medical devices and in vitro diagnostics legislation comes into force

UK lays out roadmap for regulation of software and AI as medical devices

MHRA moves to assuage medical device manufacturers over UK's post-Brexit plans

Implausible declarations?

Connect with one of our experts

Sign up for our newsletter

Legal Notice